drugset
drugset / Trial / NCT03363178

Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults

NCT03363178 ↗

Phase 1 Unknown 20 enrolled Green Cross Corporation
NaSingle-groupOpen-labelPrevention

Summary

Healthy adults will be once administered GC3107(BCG Vaccine) Intradermally.

Timeline

Start
2017-12-14
Primary completion
2018-03-31
Completion
2018-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject GC3107 Unknown 0.1 ml Other

Indications

tuberculosis